OrthoTrophix Presents Data on TPX-100, Meniscal Pathology and Structural Progression in Knee Osteoarthritis
FOSTER CITY, Calif., Nov. 9, 2026 /PRNewswire/ — OrthoTrophix, Inc., a privately held biopharmaceutical company, today announced data from two…